Alfuzosin Hydrochlorideextended release (Cipla USA Inc.)
Welcome to the PulseAid listing for the Alfuzosin Hydrochloride drug offered from Cipla USA Inc.. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cipla USA Inc. |
NON-PROPRIETARY NAME: | Alfuzosin Hydrochloride |
SUBSTANCE NAME: | ALFUZOSIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-06-30 |
END MARKETING DATE: | 0000-00-00 |
Alfuzosin Hydrochloride extended release HUMAN PRESCRIPTION DRUG Details:
Item Description | Alfuzosin Hydrochloride extended release from Cipla USA Inc. |
LABELER NAME: | Cipla USA Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2016-06-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69097-844_58bd255d-cff2-4397-a3e2-d1d126480be5 |
PRODUCT NDC: | 69097-844 |
APPLICATION NUMBER: | ANDA090284 |
Other ALFUZOSIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: